Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome
about
Cell-mediated protection in influenza infection.Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1Pathogenesis of a model gammaherpesvirus in a natural hostDissecting the host response to a gamma-herpesvirus.Protein kinase C theta is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68.Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection.The murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cellsCD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligandMurine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity.Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology.The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency.The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells.The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo.A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection.CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cellsRecall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1BAFF receptor deficiency limits gammaherpesvirus infection.Analysis of virus-specific CD4(+) t cells during long-term gammaherpesvirus infection.Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses.Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis.An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infectionLatent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68.
P2860
Q30353071-5A0C41CE-9024-4A8A-B18B-81C4625922EBQ30400133-7DAAFE07-FAE7-4E1A-9ACC-DAF971A86653Q33247469-33461907-4802-4939-9E70-04F5B1E3D108Q33484744-BC5CF64F-9476-4A6B-BD0E-549BFD06893FQ33769411-EEAA071D-A0FF-4A7E-B985-3EE4C8915762Q33772250-200C4C2D-C73F-46E3-BC43-1CD958FE3BE3Q33788837-862AE3D6-DF5B-4073-93D9-386F17FBF5EDQ33840017-D00BA138-E20D-4298-8EF3-AC1C3C6DD652Q34015827-60D04FB3-9684-4EC4-9B79-FB79E73D1E05Q34046167-85A85494-4012-4ECE-8F27-EF6BAFDAE826Q34115812-6971B8C0-E92A-4B1F-A7B4-54A6E0B54262Q34333207-550C2645-ECE7-4CCB-9B92-5CA74FED42F5Q35024341-66A1AD1C-2192-4201-A6D7-A9C5B1A82E0AQ35478892-265F9976-37EC-499E-B397-E98A1B7A8462Q35935783-1CF13B6E-186E-415F-8290-A513DE285A48Q35941613-720D6C19-A82C-47D7-9C6A-D9914C1649C6Q36397423-D7BB79FD-8CE7-4C19-9D7D-ED2C3DDE4D1DQ36509873-4D53E96A-3341-4244-95E0-3DF389D0D948Q36524534-2060F805-89B4-4B7D-A424-C17D28607999Q36667866-0D12A478-4D24-4CDE-8EA2-D8BC946353E7Q36944359-2F533517-3186-42D8-937D-97A294A086E6Q36945001-9FCFF11B-B0F2-4891-8156-F08D99400204Q36949825-E724D9BA-605E-4B13-9F9E-0B0700BD999CQ37252878-B23FEB02-1526-485F-9A71-3584F390BCE1Q37270327-9080332C-A0E6-402F-9F8B-3A4DF3997CD1Q37713920-763D1EB7-FCA0-412A-B67E-C6FAF2D68646Q39606601-55B35B3F-E767-43D8-972B-412EA1E44640Q39685855-457B4CCC-EA1A-4007-918E-B19DF0F9E342Q39778958-3470D259-07B1-4882-8A21-EBE3531403B1Q39864114-308F5C4C-1F16-4456-8496-A04155139B4FQ40909600-D26731A9-C2C9-45C2-9181-4F34B1CA9BCDQ41007071-3499AE25-E74E-47B2-9D57-99B13BD2047DQ41857406-395B47A3-E078-464C-9CE1-11AFB21D5AAB
P2860
Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@ast
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@en
type
label
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@ast
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@en
prefLabel
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@ast
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@en
P2093
P2860
P1433
P1476
Requirement for CD40 ligand, C ...... us mononucleosis-like syndrome
@en
P2093
A M Hamilton-Easton
J W Brooks
R D Cardin
P2860
P304
P577
1999-11-01T00:00:00Z